Skip to main content

Outpatient Worsening Heart Failure as a Target for Therapy: A Review.

Publication ,  Journal Article
Greene, SJ; Mentz, RJ; Felker, GM
Published in: JAMA Cardiol
March 1, 2018

IMPORTANCE: Hospitalizations for worsening heart failure (WHF) represent an enormous public health and financial burden, with physicians, health systems, and payers placing increasing emphasis on hospitalization prevention. In addition, maximizing time out of the hospital is an important patient-centered outcome. In this review, we discuss the concept of outpatient WHF, highlight the rationale and data for the outpatient treatment of WHF as an alternative to hospitalization, and examine opportunities and strategies for developing outpatient "interceptive" therapies for treatment of worsening symptoms and prevention of hospitalization. OBSERVATIONS: Worsening heart failure has traditionally been synonymous with an episode of in-hospital care for worsening symptoms. While WHF often leads to hospitalization, many patients experience WHF in the outpatient setting and carry a similarly poor prognosis. These findings support WHF as a distinct condition, independent of location of care. For those that are hospitalized, most patients have an uncomplicated clinical course, with diuretics as the only intravenous therapy. Although complicated scenarios exist, it is conceivable that improved tools for outpatient management of clinical congestion would allow a greater proportion of hospitalized patients to receive comparable care outside the hospital. Most patients with WHF have a gradual onset of congestive signs and symptoms, offering a potential window in which effective therapy may abort continued worsening and obviate the need for hospitalization. To date, outpatient WHF has received minimal attention in randomized clinical trials, but this high-risk group possesses key features that favor effective clinical trial investigation. CONCLUSIONS AND RELEVANCE: As the public health and economic burdens of heart failure continue to grow, recognizing the entity of outpatient WHF is critical. Efforts to reduce heart failure hospitalization should include developing effective therapies and care strategies for outpatient WHF. The outpatient WHF population represents a major opportunity for therapeutic advancements that could fundamentally change heart failure care delivery.

Duke Scholars

Altmetric Attention Stats
Dimensions Citation Stats

Published In

JAMA Cardiol

DOI

EISSN

2380-6591

Publication Date

March 1, 2018

Volume

3

Issue

3

Start / End Page

252 / 259

Location

United States

Related Subject Headings

  • Randomized Controlled Trials as Topic
  • Patient Selection
  • Humans
  • Heart Failure
  • Disease Progression
  • Ambulatory Care
  • 3201 Cardiovascular medicine and haematology
 

Citation

APA
Chicago
ICMJE
MLA
NLM
Greene, S. J., Mentz, R. J., & Felker, G. M. (2018). Outpatient Worsening Heart Failure as a Target for Therapy: A Review. JAMA Cardiol, 3(3), 252–259. https://doi.org/10.1001/jamacardio.2017.5250
Greene, Stephen J., Robert J. Mentz, and G Michael Felker. “Outpatient Worsening Heart Failure as a Target for Therapy: A Review.JAMA Cardiol 3, no. 3 (March 1, 2018): 252–59. https://doi.org/10.1001/jamacardio.2017.5250.
Greene SJ, Mentz RJ, Felker GM. Outpatient Worsening Heart Failure as a Target for Therapy: A Review. JAMA Cardiol. 2018 Mar 1;3(3):252–9.
Greene, Stephen J., et al. “Outpatient Worsening Heart Failure as a Target for Therapy: A Review.JAMA Cardiol, vol. 3, no. 3, Mar. 2018, pp. 252–59. Pubmed, doi:10.1001/jamacardio.2017.5250.
Greene SJ, Mentz RJ, Felker GM. Outpatient Worsening Heart Failure as a Target for Therapy: A Review. JAMA Cardiol. 2018 Mar 1;3(3):252–259.

Published In

JAMA Cardiol

DOI

EISSN

2380-6591

Publication Date

March 1, 2018

Volume

3

Issue

3

Start / End Page

252 / 259

Location

United States

Related Subject Headings

  • Randomized Controlled Trials as Topic
  • Patient Selection
  • Humans
  • Heart Failure
  • Disease Progression
  • Ambulatory Care
  • 3201 Cardiovascular medicine and haematology